Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on July 28, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

PHARM MANUF/DISTR DIV - FSA

Awarded
SPE2D2-26-R-0002Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Defense Logistics Agency awarded Contract SPE2D226D0012 to EXELAN PHARMACEUTICALS INC for the supply of Sertraline tablets in multiple strengths and bottle configurations under a firm-fixed-price, requirements-type contract with a base year and four optional years, spanning up to five years of performance. The total contract value is $22,510,720.70, with delivery terms governed by F.O.B. Destination, meaning the contractor assumes all costs and risks until goods are received at designated government or Pharmaceutical Prime Vendor facilities. The contract is governed by a comprehensive set of Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses, including mandatory requirements for cybersecurity, commercial item acquisition, whistleblower protections, small business subcontractor payment acceleration, prohibitions on telecommunications equipment from covered foreign entities, and supply chain transparency under the Federal Acquisition Supply Chain Act. Packaging and labeling must comply with strict industry standards such as GS1-128 and HIBC for barcoding, require child-proof closures, prohibit glass containers, and mandate clear visibility of NDC, lot number, and expiration data with specific dimensional and positioning guidelines to ensure compatibility with automated dispensing systems. The award follows a Lowest Price Technically Acceptable (LPTA) evaluation process, where offerors must meet all technical and past performance criteria to be eligible for award consideration, with price being the sole differentiating factor among technically acceptable bids. Contract administration is handled through commercial invoicing channels via Pharmaceutical Prime Vendors including AmerisourceBergen, Cardinal Health, DMS Pharmaceutical Group, and McKesson Corp, with no direct invoicing to the government. The contractor must ensure full compliance with FDA current Good Manufacturing Practices, maintain active NDA, ANDA, or BLA approvals for all products, report any FDA warning letters or inspection failures immediately, and provide quarterly sales reports and facility disclosures. All manufacturing sites must be disclosed, and the product's country of origin must adhere to DFARS trade agreement requirements. The contract includes provisions for accelerated payments to small business subcontractors, restrictions on inverted domestic corporations, and compliance with the American Recovery and Reinvestment Act whistleblower protections. Point of contact for contract execution is Christopher Newman, with Jason Wray designated for recall coordination. Subcontractors must be vetted under FAR 52.209-6, and the contractor is obligated to maintain up-to-date representations and certifications in SAM.gov, including disclosure of ownership structure and exclusion status.

General Info

Supply Sertraline tablets to government via firm-fixed-price contract with FDA compliance and LPTA evaluation.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

PA

Set-Aside

NONE

Documents

3
PDF, High priority: read this firstamendment
High
PDF, High priority: read this first103 pages · rfp
High
PDF

Read all 3 documents

Every page of every file, in your free workspace.

Read the documents

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Supply of Ringer's Injection, LactatedOpen now, due in 6 days
  • Sodium Chloride Injection SupplierOpen now, due in 6 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

1 update
PhaseAwarded
Posted

Solicitation

Deadline changed

Response deadline changed from Dec 10, 2025 to Dec 17, 2025.

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more

Full Description

Show more
DLA award SPE2D226D0012 posted on DIBBS. Awardee: EXELAN PHARMACEUTICALS INC (CAGE 6GFC4) Total Contract Price: $22,510,720.70 Award Date: 04-21-2026 Solicitation: SPE2D2-26-R-0002 Line items: - PHARM MANUF/DISTR DIV - FSA (NSN/Part 6505GM5021307, PR 1000213076)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS